IL17A and cancer: Third, in vitro studies demonstrated that IL-17A and duodenal ILC3s induce DUOX2/DUOXA2 expression, with the former specifically upregulating Duox2 protein, thereby driving mitochondrial-independent ROS production and DNA damage, a key mechanism in cancer progression33,37.